"Insulin, Isophane" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An intermediate-acting INSULIN preparation with onset time of 2 hours and duration of 24 hours. It is produced by crystallizing ZINC-insulin-PROTAMINES at neutral pH 7. Thus it is called neutral protamine Hagedorn for inventor Hans Christian Hagedorn.
Descriptor ID |
D007336
|
MeSH Number(s) |
D06.472.699.587.200.300.200 D12.644.548.586.200.300.200
|
Concept/Terms |
Insulin, Isophane- Insulin, Isophane
- Isophane Insulin
- Neutral Protamine Hagedorn Insulin
- Protamine Hagedorn Insulin
- Hagedorn Insulin, Protamine
- Isophane Insulin, Regular
- Regular Isophane Insulin
- Insulin, NPH
- NPH Insulin
|
Below are MeSH descriptors whose meaning is more general than "Insulin, Isophane".
Below are MeSH descriptors whose meaning is more specific than "Insulin, Isophane".
This graph shows the total number of publications written about "Insulin, Isophane" by people in this website by year, and whether "Insulin, Isophane" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin, Isophane" by people in Profiles.
-
Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trials. J Am Geriatr Soc. 2007 Nov; 55(11):1735-40.
-
Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US. Diabetes Obes Metab. 2007 Jan; 9(1):103-13.
-
Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study). Diabetes Obes Metab. 2006 Jan; 8(1):58-66.
-
Assessing the role of biphasic insulin aspart 30 as an effective and tolerable front-line therapy for type 2 diabetes. Clin Ther. 2005; 27 Suppl B:S39-41.
-
Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM. Diabetes Care. 1995 Jun; 18(6):843-51.